KEOCYT
Keocyt SA develops pharmaceutical products. It offers drugs for epilepsy and cancer treatment. Its product line includes estramustin, a solution used in the treatment of prostate cancer; streptozocin, a solution used in the treatment of neuroendocrine tumors; and phenytoin and fosphenytoin used in the treatment of epilepsy.
KEOCYT
Industry:
Pharmaceutical
Founded:
2006-01-01
Address:
Malakoff, Ile-de-France, France
Country:
France
Website Url:
http://www.keocyt.com
Status:
Active
Contact:
+33 1 42 31 07 10
Technology used in webpage:
SPF Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS Salesforce SPF DocuSign Diligent
Similar Organizations
EuPharmed
EuPharmed is develops and markets pharmaceutical products.
Official Site Inspections
http://www.keocyt.com
- Host name: 193.25.192.20.es.colt.net
- IP address: 193.25.192.20
- Location: Barcelona Spain
- Latitude: 41.3891
- Longitude: 2.1611
- Timezone: Europe/Madrid
- Postal: 08015
More informations about "Keocyt"
Keocyt - Crunchbase Company Profile & Funding
Keocyt SA develops pharmaceutical products. It offers drugs for epilepsy and cancer treatment. Its product line includes estramustin, a solution used in the treatment of prostate cancer; …See details»
Keocyt Company Profile 2024: Valuation, Investors, Acquisition
Keocyt General Information Description. Developer of specialty pharmaceutical products intended to focus on oncology and neurology. The company mainly offers medicines that are used in …See details»
RIEMSER Pharma GmbH Announces Takeover of Keocyt, a French …
May 17, 2016 Keocyt brings to market pharmaceutical products that are applied in the treatment of rare diseases, especially in cancer therapy and neurology. The Paris based company was …See details»
Keocyt - Products, Competitors, Financials, Employees, …
Keocyt is a privately owned company operating in Paris, France. Founded in 2007 by Jean-Francois Auffret and Christophe Pasik, Keocyt as specialty pharma company, focusing on …See details»
Keocyt SAS - Company Profile and News - Bloomberg Markets
Company profile page for Keocyt SAS including stock price, company news, executives, board members, and contact informationSee details»
Riemser Pharma takes over Keocyt - Manufacturing Chemist
May 12, 2014 Keocyt brings to market pharmaceutical products that are applied in the treatment of rare diseases, especially in cancer therapy and neurology. The Paris-based company was …See details»
RIEMSER Pharma acquires Keocyt - 2014-05-12 - Crunchbase
Keocyt acquired by RIEMSER Pharma . Save . Summary. Overview. Edit Overview Section. Acquired Organization: Keocyt Keocyt develops pharmaceutical products. Acquiring …See details»
KEOCYT Information - RocketReach
The NAICS codes for KEOCYT are [32, 32541, 325, 3254]. What is the SIC code for KEOCYT? The SIC codes for KEOCYT are [283, 28]. Top KEOCYT Employees Christophe Pasik Owner …See details»
Keocyt SA Company Profile, Financial and Strategic SWOT Analysis ...
Keocyt SA develops pharmaceutical products. The company offers drugs for epilepsy and cancer treatment. Its product line includes estramustin, a solution used in the treatment of prostate …See details»
Keocyt SASU: Drug pipelines, Patents, Clinical trials - Synapse
Jul 9, 2023 Explore Keocyt SASU with its drug pipeline, therapeutic area, technology platform, 1 clinical trial.See details»
Organization | Keocyt
Organization Overview. First Clinical Trial. 2017 NCT03240731. First Marketed Drug. None First NDA Approval. None Last Known Activity. 2017 Timeline < Back; View all... NOW. Now; Active …See details»
Riemser Pharma va acquérir le français Keocyt
May 21, 2014 La société allemande Riemser Pharma, fabricant de produits pharmaceutiques de spécialité, a annoncé aujourd'hui l'acquisition de la société pharmaceutique française Keocyt …See details»
Keocyt devient ESTEVE France - Industrie Mag
Keocyt, filiale française détenue par Riemser depuis 2014 et rebaptisée aujourd’hui ESTEVE France, est présente dans les domaines de la médecine neurologique et en cancérologie avec …See details»
Keocyt devient ESTEVE France - MyPharma Editions
Jun 7, 2022 En janvier 2022, la filiale française du groupe pharmaceutique ESTEVE, basé à Barcelone, a changé de nom et devient ESTEVE France. En 2 ans, avec l’acquisition du …See details»
Riemser Pharma acquires French drugmaker Keocyt
May 12, 2014 Keocyt brings to market pharmaceutical products that are applied in the treatment of rare diseases, especially in cancer therapy and neurology. The Paris based company was …See details»
Keocyt - Crunchbase
Organization. Keocyt . Connect to CRM . Save . Summary People Technology Signals & News Similar Companies. Similar Companies. Edit Similar Companies Section. Companies like …See details»
Organization | Keocyt - CDEK
Organization Overview. First Clinical Trial. 2017 NCT03240731. First Marketed Drug. None First NDA Approval. None Last Known Activity. 2017 Timeline < Back; View all... NOW. Now; Active …See details»
ESTEVE Keocyt - Forbidden DevelopmentAid
ESTEVE is a global pharmaceutical company based in Barcelona, Spain, dedicated to improving people's lives through innovation. Since its inception in 1929, it has focused on helping …See details»
How to Evolve From Manager to Mentor and Create a Lasting …
11 hours ago By sharing stories that tie back to the organization's mission and the greater purpose, or "the why" — a concept popularized by Simon Sinek — you create a narrative that …See details»
Keocyt - Tech Stack, Apps, Patents & Trademarks - Crunchbase
Organization. Keocyt . Connect to CRM . Save . Summary. People. Technology. Signals & News. Similar Companies. Highlights. Active Tech Count 6. About. Keocyt is actively using 6 …See details»